Abstract:Abstract:As a new mouse mutant resource, the RIKEN ENU-based gene-driven mutagenesis system in the mouse has been available to the research community since 2002. By using random base-substitution mutagenesis with ENU, a new reverse genetics infrastructure has been developed as a next-generation gene-targeting system. The construction of a largescale mutant mouse library and high-throughput mutation discovery systems were the keys making it practically feasible. The RIKEN mutant mouse library consists of ~10,00… Show more
“…To study the effects of mutations in different domains of TDP‐43 in vivo , at physiological levels, we selected two endogenous Tardbp mutations from a mouse allelic series found by screening mutagenised DNA archives from two large N ‐ethyl‐ N ‐nitrosourea (ENU) mouse mutagenesis programmes (Acevedo‐Arozena et al , 2008; Gondo et al , 2010). The first mutation (F210I) is located in the important RNA recognition motif 2 (RRM2) of TDP‐43; hence, we refer to this mutation as RRM2mut hereafter (Fig 1A).…”
TDP‐43 (encoded by the gene TARDBP) is an RNA binding protein central to the pathogenesis of amyotrophic lateral sclerosis (ALS). However, how TARDBP mutations trigger pathogenesis remains unknown. Here, we use novel mouse mutants carrying point mutations in endogenous Tardbp to dissect TDP‐43 function at physiological levels both in vitro and in vivo. Interestingly, we find that mutations within the C‐terminal domain of TDP‐43 lead to a gain of splicing function. Using two different strains, we are able to separate TDP‐43 loss‐ and gain‐of‐function effects. TDP‐43 gain‐of‐function effects in these mice reveal a novel category of splicing events controlled by TDP‐43, referred to as “skiptic” exons, in which skipping of constitutive exons causes changes in gene expression. In vivo, this gain‐of‐function mutation in endogenous Tardbp causes an adult‐onset neuromuscular phenotype accompanied by motor neuron loss and neurodegenerative changes. Furthermore, we have validated the splicing gain‐of‐function and skiptic exons in ALS patient‐derived cells. Our findings provide a novel pathogenic mechanism and highlight how TDP‐43 gain of function and loss of function affect RNA processing differently, suggesting they may act at different disease stages.
“…To study the effects of mutations in different domains of TDP‐43 in vivo , at physiological levels, we selected two endogenous Tardbp mutations from a mouse allelic series found by screening mutagenised DNA archives from two large N ‐ethyl‐ N ‐nitrosourea (ENU) mouse mutagenesis programmes (Acevedo‐Arozena et al , 2008; Gondo et al , 2010). The first mutation (F210I) is located in the important RNA recognition motif 2 (RRM2) of TDP‐43; hence, we refer to this mutation as RRM2mut hereafter (Fig 1A).…”
TDP‐43 (encoded by the gene TARDBP) is an RNA binding protein central to the pathogenesis of amyotrophic lateral sclerosis (ALS). However, how TARDBP mutations trigger pathogenesis remains unknown. Here, we use novel mouse mutants carrying point mutations in endogenous Tardbp to dissect TDP‐43 function at physiological levels both in vitro and in vivo. Interestingly, we find that mutations within the C‐terminal domain of TDP‐43 lead to a gain of splicing function. Using two different strains, we are able to separate TDP‐43 loss‐ and gain‐of‐function effects. TDP‐43 gain‐of‐function effects in these mice reveal a novel category of splicing events controlled by TDP‐43, referred to as “skiptic” exons, in which skipping of constitutive exons causes changes in gene expression. In vivo, this gain‐of‐function mutation in endogenous Tardbp causes an adult‐onset neuromuscular phenotype accompanied by motor neuron loss and neurodegenerative changes. Furthermore, we have validated the splicing gain‐of‐function and skiptic exons in ALS patient‐derived cells. Our findings provide a novel pathogenic mechanism and highlight how TDP‐43 gain of function and loss of function affect RNA processing differently, suggesting they may act at different disease stages.
“…A high-throughput mutation screening of ENU-mutagenized male genomic DNA library was performed as described previously444546. Four pairs of PCR primers were used for the screening and facilitated the multiplex amplification of exons 3, 5, 8–9 and 11 of the β-catenin gene (Fig.…”
Wnt/β-catenin signalling regulates numerous developmental and homeostatic processes. Ctnnb1 (also known as β-catenin) is the only protein that transmits signals from various Wnt ligands to downstream genes. In this study, we report that our newly established mouse strain, which harbours a Cys429 to Ser missense mutation in the β-catenin gene, exhibited specific organ defects in contrast to mice with broadly functioning Wnt/β-catenin signalling. Both homozygous mutant males and females produced normal gametes but were infertile because of abnormal seminal vesicle and vaginal morphogenesis. An ins-TOPGAL transgenic reporter spatiotemporally sustained Wnt/β-catenin signalling during the corresponding organogenesis. Therefore, β-cateninC429S should provide new insights into β-catenin as a universal component of Wnt/β-catenin signal transduction.
“…We generated a library of ENU-mutated mice and employed a high throughput screening system to detect mutations. We refer to these techniques collectively as RIKEN ENU-based gene-driven mutagenesis system (RGDMS) (15)(16)(17)(18). Using RGDMS to generate and analyze mice with ENU-induced mutations, we uncovered unexpected functions for Impa1 in the development of the skull, as well as in mouse behavior.…”
Background: Lithium exerts a mood-stabilizing effect and inhibits myo-inositol monophosphatase (IMPase). Results: IMPase mutant mice had impaired jaw formation and mimicked lithium-induced behaviors. Conclusion: Craniofacial development and brain function require intracellular inositol production. Significance: This mouse model reveals molecular mechanisms relevant to understanding lithium's efficacy and inositolmediated developmental processes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.